+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannula Market - Global Forecast 2026-2032- Product Image
Cannula Market - Global Forecast 2026-2032- Product Image
Sale

Cannula Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010654
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cannula Market is projected to reach USD 1.18 Billion in 2026. It is expected to continue growing at a CAGR of 7.16%, reaching USD 1.79 Billion by 2032.

The cannula market sits at the center of modern patient care, supporting vascular access, oxygen delivery, surgical suction, cardiopulmonary support, aesthetic procedures, dialysis, and drug administration. Demand is supported by durable healthcare fundamentals, including the global burden of chronic disease, aging populations, the rise of outpatient and minimally invasive procedures, and the need for reliable disposable medical devices that reduce cross-contamination and needlestick risk.

For manufacturers, providers, and distributors, the strongest opportunities are in safety-engineered IV cannulas, nasal cannulas for respiratory care, specialty cannulas for cardiac and aesthetic procedures, and advanced materials that improve flexibility, flow control, radiopacity, kink resistance, and biocompatibility. Competitive advantage increasingly depends on regulatory readiness, clinical usability, supply resilience, sterilization assurance, and evidence-based product differentiation.

Transformative Shifts in the Cannula Landscape

The cannula landscape is shifting from commodity procurement toward clinically differentiated devices. Hospitals, ambulatory surgery centers, emergency departments, and home-care settings are prioritizing cannulas that support faster placement, lower needlestick exposure, better patient comfort, reduced infiltration risk, and compatibility with infusion pumps, oxygen systems, dialysis platforms, and minimally invasive surgical workflows.

Regulation is another major force. The U.S. FDA Quality Management System Regulation alignment with ISO 13485, the European Union Medical Device Regulation, and country-specific requirements in China, India, Japan, and Brazil are raising expectations for traceability, post-market surveillance, sterilization validation, labeling control, and risk management. These shifts favor manufacturers with strong quality systems, validated production processes, and transparent clinical and technical evidence packages.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the cannula value chain through product design simulation, visual inspection, production yield optimization, demand planning, inventory analytics, and clinical workflow support. In manufacturing, AI-enabled machine vision can help identify surface defects, dimensional variation, burrs, particulate contamination, packaging issues, and labeling inconsistencies before release, supporting stronger quality assurance and fewer preventable deviations.

In care delivery, AI is most relevant where cannulas intersect with monitoring systems, infusion management, respiratory support, ultrasound-guided access, and image-guided procedures. While cannulas themselves remain regulated medical devices that require validated performance evidence, AI can improve training, placement guidance, adverse event signal detection, stock allocation, and procedure readiness when deployed within compliant clinical, cybersecurity, and quality management frameworks.

Key Regional Insights for Cannula Demand

Asia-Pacific is one of the most dynamic regions for cannula demand, supported by expanding hospital capacity, rising procedure volumes, medical tourism, and large patient populations in China, India, Japan, South Korea, and Australia. Healthcare investments, domestic medical device manufacturing, and broader access to surgical, infusion, and respiratory care are strengthening demand for IV cannulas, nasal cannulas, and specialty cannulas across the region. North America remains a high-value environment due to advanced hospital infrastructure, strong adoption of safety-engineered vascular access devices, established reimbursement pathways for acute and ambulatory care, and rigorous infection prevention practices.

Europe is shaped by strict medical device regulation, strong infection prevention standards, centralized procurement, and demand for high-quality cannulas used in surgery, respiratory care, infusion therapy, and critical care. Latin America is expanding through public and private healthcare investment, particularly in Brazil and Mexico, where hospital modernization and growing procedure access support device utilization. The Middle East benefits from hospital modernization, emergency care upgrades, and specialty care investment, while Africa shows long-term growth potential as access to essential medical devices, oxygen therapy, maternal care, dialysis, and surgical capacity improves through public health programs and infrastructure development.

Key Group Insights Across Healthcare Alliances

ASEAN markets are benefiting from healthcare infrastructure expansion, regional medical tourism, and growing use of disposable medical devices in hospitals, clinics, and ambulatory care facilities. GCC countries are investing in tertiary care, emergency medicine, oncology, cardiology, and specialty hospitals, creating demand for premium cannulas used in respiratory support, infusion therapy, intensive care, and surgical procedures.

The European Union is defined by MDR compliance, sustainability expectations, strong procurement standards, and an emphasis on traceability and post-market surveillance. BRICS economies combine scale with manufacturing opportunity, especially in China, India, and Brazil, while also reflecting rising demand for cost-effective and clinically reliable cannula products. G7 countries continue to lead in premium device adoption, clinical safety protocols, quality assurance, and innovation funding, while NATO member states emphasize resilient medical supply chains, emergency preparedness, and standardized procurement for critical medical consumables.

Key Country Insights for Cannula Growth

The United States leads in high-value cannula adoption, supported by advanced hospitals, ambulatory surgery centers, emergency care networks, home infusion services, and safety-focused procurement. Canada emphasizes quality, public healthcare purchasing, respiratory care access, and standardized clinical protocols, while Mexico is supported by nearshoring, medical device manufacturing, private hospital expansion, and cross-border healthcare activity. Brazil anchors Latin American demand through its large population, mixed public-private healthcare system, and expanding access to surgical, infusion, and respiratory care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature demand for IV, nasal, surgical, and specialty cannulas, with Germany standing out for engineering capability, hospital infrastructure, and medtech manufacturing depth. France and the United Kingdom prioritize quality, safety, and public procurement discipline, while Italy and Spain benefit from established hospital networks and procedure-based care. Russia’s demand is shaped by domestic supply priorities and healthcare self-sufficiency efforts. In Asia-Pacific, China and India offer scale through large patient populations, hospital expansion, and domestic production, Japan and South Korea prioritize precision, quality, and advanced clinical use, and Australia shows steady demand through hospital modernization, respiratory care capacity, and high clinical standards.

Actionable Recommendations for Cannula Leaders

Industry leaders should prioritize clinically differentiated cannulas that address safety, comfort, flow reliability, insertion performance, secure fixation, and ease of use. Products with clear performance evidence, validated sterility, secure supply continuity, and compatibility with hospital protocols are better positioned in value-based procurement environments where clinical outcomes and operational reliability increasingly influence purchasing decisions.

Manufacturers should strengthen regulatory intelligence, invest in automated inspection, diversify suppliers for polymers, needles, packaging, and sterilization services, and localize distribution in high-growth regions. Providers and distributors should evaluate total cost of ownership, including failure rates, staff training burden, infection prevention outcomes, product standardization, stockout risk, and inventory resilience rather than relying only on unit price.

Research Methodology

This executive summary is developed using a structured research approach combining secondary data review, regulatory intelligence, product category assessment, market participant analysis, and healthcare demand indicators. Verified sources considered include public materials from the U.S. FDA, European Commission, WHO, OECD, national health agencies, standards bodies, and recognized medical device regulatory frameworks, including requirements relevant to quality management, sterilization, labeling, biocompatibility, and post-market surveillance.

The methodology emphasizes triangulation across clinical need, procedure trends, regulatory requirements, product categories, procurement behavior, infection prevention practices, healthcare infrastructure investment, and regional access conditions. Insights are framed qualitatively where public data do not support precise market sizing, market share, or forecasting, ensuring that conclusions remain evidence-based, transparent, and suitable for executive decision-making.

Conclusion

The cannula market is expected to remain essential to global healthcare because cannulas enable routine and critical interventions across vascular access, respiratory therapy, surgery, dialysis, cardiology, anesthesia, emergency medicine, and aesthetics. Momentum is tied to the expansion of procedure-based care, aging populations, chronic disease management, infection prevention priorities, and the continued shift toward disposable, safety-focused medical devices.

The strongest participants will be those that combine regulatory discipline, manufacturing quality, clinical usability, material innovation, and regional access strategies. As AI, automation, and advanced materials reshape product development, quality control, and supply chains, cannula manufacturers and healthcare partners that deliver measurable clinical and operational value will be best positioned for sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cannula Market, by Product Type
7.1. Introduction
7.2. Vascular Cannula
7.2.1. Arterial Cannula
7.2.2. Venous Cannula
7.3. Intravenous Cannula
7.3.1. Peripheral IV Cannula
7.3.2. Safety IV Cannula
8. Cannula Market, by Material Type
8.1. Introduction
8.2. Plastic
8.2.1. PVC
8.2.2. Polyurethane
8.3. Stainless Steel
8.4. Silicone
9. Cannula Market, by Usage
9.1. Introduction
9.2. Single-use
9.3. Reusable
10. Cannula Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Cardiopulmonary Bypass
10.2.2. ECMO Procedures
10.2.3. Cardiac Surgeries
10.3. Respiratory
10.3.1. Oxygen Therapy
10.3.2. Ventilation Assistance
10.4. Dialysis
10.5. Drug Delivery
10.5.1. Intravenous Infusion Therapy
10.5.2. Chemotherapy Administration
10.5.3. Fluid & Electrolyte Delivery
10.6. Diagnostic
10.7. Surgical
10.7.1. Minimally Invasive Surgeries
10.7.2. Laparoscopic Procedures
10.7.3. Arthroscopic Procedures
10.8. Neonatal & Pediatric Care
11. Cannula Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Homecare Settings
11.4. Hospitals
11.5. Specialty Clinics
12. Cannula Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Cannula Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Cannula Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Angiplast Pvt Ltd
16.2. Argon Medical Devices, Inc.
16.3. B. Braun Melsungen AG
16.4. Baihe Medical Technology Co., Ltd.
16.5. Becton, Dickinson and Company
16.6. Boston Scientific Corporation
16.7. CONMED Corporation
16.8. Cook Medical LLC
16.9. Edwards Lifesciences Corporation
16.10. Hindustan Syringes & Medical Devices Ltd
16.11. ICU Medical, Inc.
16.12. iLife Medical Devices Private Limited
16.13. Iscon Surgicals Ltd.
16.14. LivaNova PLC
16.15. Mais India Medical Devices Pvt Ltd
16.16. Mediplus (India) Ltd
16.17. Medtronic plc
16.18. Nipro Corporation
16.19. Poly Medicure Limited
16.20. Romsons Scientific & Surgical Ind Pvt Ltd
16.21. Smith & Nephew plc
16.22. Smiths Medical, Inc.
16.23. Teleflex Incorporated
16.24. Terumo Corporation
16.25. Vygon SAS
List of Figures
FIGURE 1. GLOBAL CANNULA MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CANNULA MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CANNULA MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CANNULA MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CANNULA MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CANNULA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CANNULA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANNULA MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CANNULA MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANNULA MARKET SIZE, BY USAGE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CANNULA MARKET SIZE, BY USAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CANNULA MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CANNULA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CANNULA MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CANNULA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CANNULA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CANNULA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CANNULA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CANNULA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CANNULA MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CANNULA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CANNULA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CANNULA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CANNULA MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL VASCULAR CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL VASCULAR CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL VASCULAR CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ARTERIAL CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ARTERIAL CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ARTERIAL CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL VENOUS CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL VENOUS CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL VENOUS CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PERIPHERAL IV CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PERIPHERAL IV CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PERIPHERAL IV CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SAFETY IV CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SAFETY IV CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SAFETY IV CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PLASTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PLASTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PLASTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PVC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PVC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PVC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SILICONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SINGLE-USE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SINGLE-USE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SINGLE-USE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL REUSABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL REUSABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL REUSABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIOPULMONARY BYPASS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ECMO PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ECMO PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ECMO PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIAC SURGERIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIAC SURGERIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIAC SURGERIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL OXYGEN THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL OXYGEN THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL OXYGEN THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL VENTILATION ASSISTANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL VENTILATION ASSISTANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL VENTILATION ASSISTANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DIALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INTRAVENOUS INFUSION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL INTRAVENOUS INFUSION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INTRAVENOUS INFUSION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CHEMOTHERAPY ADMINISTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CHEMOTHERAPY ADMINISTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CHEMOTHERAPY ADMINISTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL FLUID & ELECTROLYTE DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL FLUID & ELECTROLYTE DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FLUID & ELECTROLYTE DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SURGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SURGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SURGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL LAPAROSCOPIC PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL LAPAROSCOPIC PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL LAPAROSCOPIC PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ARTHROSCOPIC PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ARTHROSCOPIC PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ARTHROSCOPIC PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL NEONATAL & PEDIATRIC CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL NEONATAL & PEDIATRIC CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL NEONATAL & PEDIATRIC CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 127. EUROPE CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 130. EUROPE CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 131. EUROPE CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 132. EUROPE CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 133. EUROPE CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. EUROPE CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 136. EUROPE CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 137. EUROPE CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 138. EUROPE CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 139. EUROPE CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. AFRICA CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. AFRICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. AFRICA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 169. AFRICA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 170. AFRICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 171. AFRICA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 172. AFRICA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 173. AFRICA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. AFRICA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 175. AFRICA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 176. AFRICA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 177. AFRICA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 178. AFRICA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CANNULA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. NATO CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. NATO CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. NATO CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 196. NATO CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 197. NATO CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 198. NATO CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 199. NATO CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 200. NATO CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. NATO CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 202. NATO CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 203. NATO CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 204. NATO CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 205. NATO CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. G7 CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. G7 CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. G7 CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 209. G7 CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 210. G7 CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 211. G7 CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 212. G7 CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 213. G7 CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. G7 CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 215. G7 CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 216. G7 CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 217. G7 CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 218. G7 CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. BRICS CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. BRICS CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. BRICS CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 222. BRICS CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 223. BRICS CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 224. BRICS CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 225. BRICS CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 226. BRICS CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 227. BRICS CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 228. BRICS CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 229. BRICS CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 230. BRICS CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 231. BRICS CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. ASEAN CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. ASEAN CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. ASEAN CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 248. ASEAN CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 249. ASEAN CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 250. ASEAN CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 251. ASEAN CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 252. ASEAN CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. ASEAN CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 254. ASEAN CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 255. ASEAN CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 256. ASEAN CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 257. ASEAN CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. GCC CANNULA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. GCC CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. GCC CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 261. GCC CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 262. GCC CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. GCC CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 264. GCC CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 265. GCC CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. GCC CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 267. GCC CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 268. GCC CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 269. GCC CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 270. GCC CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL CANNULA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 272. CHINA CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. CHINA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. CHINA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 275. CHINA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 276. CHINA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 277. CHINA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 278. CHINA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 279. CHINA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. CHINA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 281. CHINA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 282. CHINA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 283. CHINA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 284. CHINA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. JAPAN CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. JAPAN CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 300. JAPAN CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 301. JAPAN CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 302. JAPAN CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 303. JAPAN CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 304. JAPAN CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 305. JAPAN CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. JAPAN CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 307. JAPAN CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 308. JAPAN CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 309. JAPAN CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 310. JAPAN CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. INDIA CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. INDIA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. INDIA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 314. INDIA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 315. INDIA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 316. INDIA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 317. INDIA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 318. INDIA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. INDIA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 320. INDIA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 321. INDIA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 322. INDIA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 323. INDIA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. GERMANY CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. GERMANY CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. GERMANY CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 327. GERMANY CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 328. GERMANY CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 329. GERMANY CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 330. GERMANY CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 331. GERMANY CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. GERMANY CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 333. GERMANY CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 334. GERMANY CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 335. GERMANY CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 336. GERMANY CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 347. UNITED KINGDOM CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 348. UNITED KINGDOM CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 349. UNITED KINGDOM CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 350. AUSTRALIA CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. AUSTRALIA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 352. AUSTRALIA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 353. AUSTRALIA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 359. AUSTRALIA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 360. AUSTRALIA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 361. AUSTRALIA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 362. AUSTRALIA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. FRANCE CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 364. FRANCE CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 365. FRANCE CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 366. FRANCE CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 367. FRANCE CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 368. FRANCE CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 369. FRANCE CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 370. FRANCE CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 371. FRANCE CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 372. FRANCE CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 373. FRANCE CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 374. FRANCE CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 375. FRANCE CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 376. SOUTH KOREA CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 377. SOUTH KOREA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 378. SOUTH KOREA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 379. SOUTH KOREA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 380. SOUTH KOREA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 381. SOUTH KOREA CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 382. SOUTH KOREA CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 383. SOUTH KOREA CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 384. SOUTH KOREA CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 385. SOUTH KOREA CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 386. SOUTH KOREA CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 387. SOUTH KOREA CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 388. SOUTH KOREA CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 389. ITALY CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 390. ITALY CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 391. ITALY CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 392. ITALY CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 393. ITALY CANNULA MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 394. ITALY CANNULA MARKET SIZE, BY PLASTIC, 2017-2032 (USD MILLION)
TABLE 395. ITALY CANNULA MARKET SIZE, BY USAGE, 2017-2032 (USD MILLION)
TABLE 396. ITALY CANNULA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 397. ITALY CANNULA MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 398. ITALY CANNULA MARKET SIZE, BY RESPIRATORY, 2017-2032 (USD MILLION)
TABLE 399. ITALY CANNULA MARKET SIZE, BY DRUG DELIVERY, 2017-2032 (USD MILLION)
TABLE 400. ITALY CANNULA MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 401. ITALY CANNULA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 402. CANADA CANNULA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 403. CANADA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 404. CANADA CANNULA MARKET SIZE, BY VASCULAR CANNULA, 2017-2032 (USD MILLION)
TABLE 405. CANADA CANNULA MARKET SIZE, BY INTRAVENOUS CANNULA, 2017-2032 (USD MILLION)
TABLE 406. CANADA CANNULA MARKET SIZE, BY MATERIAL TY

Companies Mentioned

  • Angiplast Pvt Ltd
  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Baihe Medical Technology Co., Ltd.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd
  • ICU Medical, Inc.
  • iLife Medical Devices Private Limited
  • Iscon Surgicals Ltd.
  • LivaNova PLC
  • Mais India Medical Devices Pvt Ltd
  • Mediplus (India) Ltd
  • Medtronic plc
  • Nipro Corporation
  • Poly Medicure Limited
  • Romsons Scientific & Surgical Ind Pvt Ltd
  • Smith & Nephew plc
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.18 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.79 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

High Flow Oxygen Nasal Cannula Market - Global Forecast 2026-2032 - Product Image

High Flow Oxygen Nasal Cannula Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
High-flow Nasal Cannula Market - Global Forecast 2026-2032 - Product Image

High-flow Nasal Cannula Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Cannula - Global Strategic Business Report - Product Image

Cannula - Global Strategic Business Report

  • Report
  • 484 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report

  • Report
  • 463 Pages
  • Global
From
Cannula Market Report by Product, Type, Size, Material, Application, End-User, and Region 2026-2034 - Product Image

Cannula Market Report by Product, Type, Size, Material, Application, End-User, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.